Heart Failure Clinical Trial

Change in Stroke Volume Index After Diuresis for Patients With Decompensated Heart Failure

Summary

This is a prospective cohort study for 50 patients admitted to the cardiac care unit requiring clinically-indicated diuretic therapy for congestive heart failure. The purpose of this study is to assess the role of non-invasive cardiac output monitoring (NICOM) with the Starling Fluid Management System (Baxter Medical, Deerfield, IL) in determining volume status in patients with acute decompensated heart failure requiring intravenous diuretic therapy.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Diagnosis of congestive acute decompensated heart failure (preserved or reduced ejection fraction) requiring clinically indicated IV diuresis
Admission to coronary/cardiac intensive care unit or cardiac step down unit
Able to provide written informed consent
Anticipated need for IV diuretics > 24 hrs

Exclusion Criteria:

Prisoner, pregnancy or post-partum stage, or age < 18 years
Known allergy to sensory material or gel
End stage renal disease or need for CRRT
Inability or contraindication to do a passive leg raise with both extremities (i.e., balloon pump, impella, spinal injury, amputation)
Other situation that might increase subject risk, interfere with study procedures, or confound study findings based on the opinion of the clinician/investigator
Inability to provide informed consent

Study is for people with:

Heart Failure

Estimated Enrollment:

50

Study ID:

NCT05240651

Recruitment Status:

Recruiting

Sponsor:

NYU Langone Health

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

NYU Langone Health
New York New York, 10016, United States More Info
Carlos Alviar, MD
Principal Investigator
Stuart Katz, MD
Sub-Investigator
Nicholas Kiefer, MD
Sub-Investigator

How clear is this clinincal trial information?

Study is for people with:

Heart Failure

Estimated Enrollment:

50

Study ID:

NCT05240651

Recruitment Status:

Recruiting

Sponsor:


NYU Langone Health

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.